| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromuscular Blocking Agents | 7 | 2013 | 28 | 1.240 |
Why?
|
| Critical Care | 14 | 2013 | 483 | 1.140 |
Why?
|
| Catheterization, Swan-Ganz | 7 | 2007 | 24 | 1.120 |
Why?
|
| Monitoring, Physiologic | 15 | 2022 | 263 | 0.940 |
Why?
|
| Intensive Care Units | 9 | 2013 | 520 | 0.880 |
Why?
|
| Public Policy | 3 | 2014 | 61 | 0.870 |
Why?
|
| Marketing | 2 | 2014 | 24 | 0.830 |
Why?
|
| Organizational Policy | 2 | 2014 | 56 | 0.820 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2012 | 508 | 0.810 |
Why?
|
| Cardiopulmonary Bypass | 8 | 2007 | 161 | 0.810 |
Why?
|
| Drug Industry | 2 | 2014 | 57 | 0.800 |
Why?
|
| Anesthesiology | 6 | 2022 | 171 | 0.700 |
Why?
|
| Neuromuscular Blockade | 6 | 2015 | 29 | 0.650 |
Why?
|
| Oximetry | 5 | 2015 | 94 | 0.640 |
Why?
|
| Laryngeal Masks | 1 | 2020 | 14 | 0.630 |
Why?
|
| Critical Illness | 11 | 2013 | 436 | 0.600 |
Why?
|
| Airway Management | 1 | 2020 | 53 | 0.590 |
Why?
|
| Anesthesia Recovery Period | 11 | 2015 | 56 | 0.570 |
Why?
|
| Fentanyl | 5 | 2009 | 92 | 0.560 |
Why?
|
| Anesthesia | 5 | 2022 | 174 | 0.560 |
Why?
|
| Catheterization, Peripheral | 3 | 2009 | 62 | 0.550 |
Why?
|
| Physicians | 3 | 2014 | 685 | 0.530 |
Why?
|
| Morphine | 3 | 2009 | 127 | 0.530 |
Why?
|
| Postoperative Complications | 12 | 2015 | 2680 | 0.520 |
Why?
|
| Monitoring, Intraoperative | 9 | 2017 | 116 | 0.520 |
Why?
|
| Coronary Artery Bypass | 6 | 2007 | 231 | 0.510 |
Why?
|
| Hypotension | 1 | 2017 | 80 | 0.490 |
Why?
|
| Ventricular Function | 2 | 2007 | 41 | 0.480 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 4 | 2008 | 17 | 0.420 |
Why?
|
| Intraoperative Care | 3 | 2022 | 90 | 0.420 |
Why?
|
| Anesthetics, Intravenous | 4 | 2009 | 45 | 0.400 |
Why?
|
| Airway Obstruction | 4 | 2015 | 112 | 0.400 |
Why?
|
| Analgesics, Opioid | 4 | 2017 | 539 | 0.390 |
Why?
|
| Hemodynamics | 9 | 2014 | 747 | 0.390 |
Why?
|
| Humans | 79 | 2022 | 98135 | 0.360 |
Why?
|
| Blood Gas Analysis | 6 | 2004 | 35 | 0.350 |
Why?
|
| Brain Ischemia | 2 | 2012 | 416 | 0.330 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2007 | 266 | 0.320 |
Why?
|
| Hypoxia | 7 | 2015 | 699 | 0.320 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2015 | 70 | 0.320 |
Why?
|
| Anesthesia, General | 5 | 2022 | 132 | 0.320 |
Why?
|
| Catheter-Related Infections | 1 | 2009 | 26 | 0.300 |
Why?
|
| Pulmonary Artery | 3 | 2009 | 342 | 0.290 |
Why?
|
| Patient-Centered Care | 4 | 2015 | 233 | 0.290 |
Why?
|
| Perioperative Care | 3 | 2015 | 198 | 0.290 |
Why?
|
| Bacitracin | 1 | 2008 | 4 | 0.280 |
Why?
|
| Bacteremia | 1 | 2009 | 111 | 0.280 |
Why?
|
| Anaphylaxis | 1 | 2008 | 29 | 0.270 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 67 | 0.270 |
Why?
|
| Blood Transfusion | 2 | 2006 | 180 | 0.260 |
Why?
|
| Elective Surgical Procedures | 3 | 2010 | 171 | 0.260 |
Why?
|
| Health Care Costs | 1 | 2009 | 256 | 0.260 |
Why?
|
| Spinal Fractures | 1 | 2008 | 103 | 0.250 |
Why?
|
| Intraoperative Complications | 2 | 2008 | 194 | 0.250 |
Why?
|
| Brain | 2 | 2015 | 2448 | 0.250 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 164 | 0.240 |
Why?
|
| Mediastinoscopy | 1 | 2006 | 4 | 0.240 |
Why?
|
| Muscle Weakness | 6 | 2015 | 69 | 0.240 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2006 | 12 | 0.240 |
Why?
|
| Analgesics | 2 | 2004 | 131 | 0.240 |
Why?
|
| Hypnotics and Sedatives | 2 | 2004 | 143 | 0.230 |
Why?
|
| Aged | 26 | 2017 | 21760 | 0.230 |
Why?
|
| Embolism, Air | 2 | 2006 | 21 | 0.230 |
Why?
|
| Cardiac Output | 6 | 2004 | 142 | 0.220 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 139 | 0.220 |
Why?
|
| Middle Aged | 30 | 2017 | 29442 | 0.220 |
Why?
|
| Prospective Studies | 10 | 2018 | 4825 | 0.220 |
Why?
|
| Double-Blind Method | 10 | 2017 | 1783 | 0.220 |
Why?
|
| Female | 36 | 2017 | 51570 | 0.220 |
Why?
|
| Heart Diseases | 1 | 2007 | 268 | 0.210 |
Why?
|
| Point-of-Care Systems | 2 | 1996 | 155 | 0.210 |
Why?
|
| Radial Artery | 1 | 2004 | 41 | 0.210 |
Why?
|
| Emergencies | 2 | 1995 | 122 | 0.210 |
Why?
|
| Blood Pressure | 5 | 2017 | 910 | 0.210 |
Why?
|
| Muscle Relaxants, Central | 1 | 2003 | 11 | 0.200 |
Why?
|
| Male | 32 | 2017 | 47109 | 0.200 |
Why?
|
| Antiemetics | 2 | 2014 | 28 | 0.190 |
Why?
|
| Anesthesia, Endotracheal | 1 | 2022 | 6 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 881 | 0.180 |
Why?
|
| Analgesia, Epidural | 1 | 2002 | 42 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2006 | 540 | 0.180 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2022 | 72 | 0.180 |
Why?
|
| Patient Positioning | 2 | 2014 | 70 | 0.170 |
Why?
|
| Publishing | 1 | 2003 | 97 | 0.170 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2001 | 38 | 0.170 |
Why?
|
| Vital Capacity | 1 | 2001 | 74 | 0.170 |
Why?
|
| Patient Handoff | 1 | 2022 | 100 | 0.160 |
Why?
|
| Dexamethasone | 2 | 2014 | 318 | 0.160 |
Why?
|
| Delirium | 1 | 2001 | 82 | 0.160 |
Why?
|
| Clinical Trials as Topic | 3 | 2016 | 1131 | 0.160 |
Why?
|
| Oxygen | 6 | 2010 | 801 | 0.160 |
Why?
|
| Methadone | 2 | 2017 | 54 | 0.160 |
Why?
|
| Sepsis | 1 | 2004 | 427 | 0.150 |
Why?
|
| Anxiety | 2 | 2001 | 370 | 0.150 |
Why?
|
| Respiration, Artificial | 5 | 2014 | 462 | 0.150 |
Why?
|
| Pancuronium | 3 | 2004 | 7 | 0.150 |
Why?
|
| Androstanols | 3 | 2004 | 12 | 0.150 |
Why?
|
| Adult | 28 | 2017 | 29564 | 0.150 |
Why?
|
| Blood Chemical Analysis | 2 | 1996 | 40 | 0.140 |
Why?
|
| Pain | 1 | 2001 | 416 | 0.140 |
Why?
|
| Analgesia | 2 | 2001 | 65 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2001 | 391 | 0.140 |
Why?
|
| Safety Management | 1 | 2018 | 54 | 0.140 |
Why?
|
| Clinical Competence | 3 | 2001 | 865 | 0.140 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2017 | 5 | 0.130 |
Why?
|
| Length of Stay | 6 | 2015 | 878 | 0.130 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 132 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2017 | 23 | 0.130 |
Why?
|
| Thermodilution | 3 | 2004 | 18 | 0.130 |
Why?
|
| Postoperative Nausea and Vomiting | 3 | 2014 | 19 | 0.120 |
Why?
|
| Opiate Substitution Treatment | 1 | 2017 | 54 | 0.120 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 480 | 0.120 |
Why?
|
| Parenting | 1 | 2017 | 70 | 0.120 |
Why?
|
| Documentation | 1 | 2017 | 111 | 0.120 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 511 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2004 | 84 | 0.120 |
Why?
|
| Patient Safety | 1 | 2018 | 235 | 0.120 |
Why?
|
| Family Health | 2 | 2005 | 156 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 365 | 0.110 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 153 | 0.110 |
Why?
|
| Spinal Fusion | 2 | 2017 | 371 | 0.110 |
Why?
|
| Myography | 2 | 2011 | 5 | 0.110 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 410 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2014 | 42 | 0.100 |
Why?
|
| Conflict of Interest | 1 | 2014 | 76 | 0.100 |
Why?
|
| Catheterization, Central Venous | 3 | 2000 | 114 | 0.100 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 303 | 0.100 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2014 | 184 | 0.100 |
Why?
|
| Informed Consent | 1 | 2016 | 284 | 0.100 |
Why?
|
| Blood Glucose | 2 | 2014 | 913 | 0.100 |
Why?
|
| Status Asthmaticus | 1 | 2013 | 9 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 239 | 0.100 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 255 | 0.100 |
Why?
|
| Paralysis | 3 | 2005 | 33 | 0.090 |
Why?
|
| Aged, 80 and over | 9 | 2017 | 7387 | 0.090 |
Why?
|
| Myocardial Infarction | 3 | 2009 | 396 | 0.090 |
Why?
|
| Patient Selection | 1 | 2016 | 725 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2017 | 9713 | 0.090 |
Why?
|
| Incidence | 2 | 2015 | 1777 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 413 | 0.090 |
Why?
|
| Equipment Design | 4 | 2000 | 427 | 0.080 |
Why?
|
| Models, Organizational | 2 | 2015 | 47 | 0.080 |
Why?
|
| Data Collection | 1 | 2012 | 376 | 0.080 |
Why?
|
| Intubation, Intratracheal | 4 | 2005 | 216 | 0.080 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2011 | 52 | 0.080 |
Why?
|
| Forecasting | 3 | 2015 | 295 | 0.080 |
Why?
|
| Adolescent | 5 | 2017 | 10097 | 0.080 |
Why?
|
| Fatigue | 1 | 2011 | 187 | 0.080 |
Why?
|
| Anesthesia, Intravenous | 1 | 2009 | 36 | 0.070 |
Why?
|
| Contraindications | 1 | 2009 | 66 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2013 | 321 | 0.070 |
Why?
|
| Arthroscopy | 1 | 2010 | 110 | 0.070 |
Why?
|
| Shoulder Joint | 1 | 2010 | 100 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 1109 | 0.070 |
Why?
|
| Intraoperative Period | 2 | 2022 | 93 | 0.070 |
Why?
|
| Young Adult | 3 | 2017 | 7511 | 0.070 |
Why?
|
| Telemedicine | 1 | 2012 | 250 | 0.070 |
Why?
|
| United States | 5 | 2016 | 8193 | 0.070 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2008 | 27 | 0.070 |
Why?
|
| Butyrylcholinesterase | 1 | 1988 | 12 | 0.070 |
Why?
|
| Cholinesterases | 1 | 1988 | 16 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2008 | 93 | 0.070 |
Why?
|
| Laminectomy | 1 | 2008 | 63 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1012 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2012 | 829 | 0.070 |
Why?
|
| Computers | 1 | 1987 | 102 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2013 | 2585 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1988 | 130 | 0.060 |
Why?
|
| Expert Testimony | 1 | 2007 | 34 | 0.060 |
Why?
|
| Heart Function Tests | 1 | 2007 | 29 | 0.060 |
Why?
|
| Systole | 1 | 2007 | 81 | 0.060 |
Why?
|
| Nerve Block | 2 | 2010 | 55 | 0.060 |
Why?
|
| Axillary Artery | 1 | 2006 | 12 | 0.060 |
Why?
|
| Diastole | 1 | 2007 | 101 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2006 | 37 | 0.060 |
Why?
|
| Plasmapheresis | 1 | 1986 | 26 | 0.060 |
Why?
|
| Central Venous Pressure | 1 | 2006 | 28 | 0.060 |
Why?
|
| Hemoglobins | 2 | 1998 | 198 | 0.060 |
Why?
|
| Cardiac Catheterization | 1 | 1988 | 307 | 0.060 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 137 | 0.060 |
Why?
|
| Lactation | 1 | 2006 | 57 | 0.060 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2006 | 18 | 0.060 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2006 | 33 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 1784 | 0.060 |
Why?
|
| Troponin I | 1 | 2006 | 27 | 0.060 |
Why?
|
| Milk, Human | 1 | 2006 | 54 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 193 | 0.060 |
Why?
|
| Risk Factors | 3 | 2012 | 6232 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 62 | 0.060 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 57 | 0.060 |
Why?
|
| Consumer Behavior | 1 | 2005 | 35 | 0.060 |
Why?
|
| Heart | 1 | 1988 | 527 | 0.060 |
Why?
|
| Heparin | 1 | 1986 | 182 | 0.060 |
Why?
|
| Anesthesia, Inhalation | 1 | 2005 | 36 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 1986 | 194 | 0.050 |
Why?
|
| Prognosis | 1 | 2013 | 4116 | 0.050 |
Why?
|
| Arteries | 3 | 2000 | 171 | 0.050 |
Why?
|
| Carotid Artery, Common | 1 | 2004 | 28 | 0.050 |
Why?
|
| Information Management | 1 | 2004 | 7 | 0.050 |
Why?
|
| Extracorporeal Circulation | 1 | 2004 | 37 | 0.050 |
Why?
|
| Propofol | 2 | 2006 | 95 | 0.050 |
Why?
|
| Health Priorities | 1 | 2004 | 30 | 0.050 |
Why?
|
| Nurses | 1 | 2004 | 42 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 2004 | 102 | 0.050 |
Why?
|
| Family | 1 | 2005 | 327 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2004 | 123 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 154 | 0.050 |
Why?
|
| Nervous System | 1 | 2003 | 92 | 0.050 |
Why?
|
| Embolism | 1 | 1982 | 32 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2004 | 157 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1998 | 244 | 0.040 |
Why?
|
| Linear Models | 1 | 2003 | 424 | 0.040 |
Why?
|
| Patient Care Team | 2 | 2015 | 320 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2004 | 977 | 0.040 |
Why?
|
| Echocardiography | 1 | 2006 | 783 | 0.040 |
Why?
|
| Breast Feeding | 2 | 2017 | 113 | 0.040 |
Why?
|
| Hand | 1 | 1982 | 144 | 0.040 |
Why?
|
| Hypothermia | 1 | 2001 | 27 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2004 | 464 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2001 | 65 | 0.040 |
Why?
|
| Catheterization | 1 | 1982 | 219 | 0.040 |
Why?
|
| Research Design | 1 | 2005 | 660 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 3 | 1992 | 55 | 0.040 |
Why?
|
| Ventricular Fibrillation | 1 | 2001 | 73 | 0.040 |
Why?
|
| Electric Countershock | 1 | 2001 | 77 | 0.040 |
Why?
|
| Ischemia | 1 | 1982 | 262 | 0.040 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2000 | 9 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 685 | 0.040 |
Why?
|
| Edetic Acid | 1 | 2000 | 40 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 68 | 0.040 |
Why?
|
| Heart Rate | 2 | 2014 | 536 | 0.040 |
Why?
|
| Pain Measurement | 3 | 2009 | 401 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 522 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2001 | 315 | 0.040 |
Why?
|
| Compliance | 1 | 2018 | 16 | 0.040 |
Why?
|
| Time Factors | 2 | 2010 | 5576 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2001 | 162 | 0.030 |
Why?
|
| Postoperative Period | 2 | 2011 | 322 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 1998 | 102 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1996 | 488 | 0.030 |
Why?
|
| Biosensing Techniques | 2 | 1996 | 84 | 0.030 |
Why?
|
| Credentialing | 1 | 1997 | 16 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1998 | 92 | 0.030 |
Why?
|
| Homeostasis | 1 | 2000 | 474 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 889 | 0.030 |
Why?
|
| Carbon Dioxide | 2 | 2014 | 202 | 0.030 |
Why?
|
| Buprenorphine | 1 | 2017 | 57 | 0.030 |
Why?
|
| Hematocrit | 1 | 1996 | 68 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 1996 | 31 | 0.030 |
Why?
|
| Atracurium | 1 | 1995 | 5 | 0.030 |
Why?
|
| Vecuronium Bromide | 1 | 1995 | 3 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 1995 | 38 | 0.030 |
Why?
|
| Educational Measurement | 1 | 1997 | 241 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1996 | 155 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 2015 | 42 | 0.030 |
Why?
|
| Professional-Family Relations | 2 | 2005 | 60 | 0.030 |
Why?
|
| Acid-Base Imbalance | 1 | 1995 | 4 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 764 | 0.030 |
Why?
|
| Health Care Reform | 1 | 1995 | 78 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 30 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2014 | 31 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 137 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1995 | 63 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1994 | 24 | 0.030 |
Why?
|
| Shoulder | 1 | 2014 | 44 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 66 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2015 | 3213 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2005 | 346 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 80 | 0.030 |
Why?
|
| Logistic Models | 2 | 2010 | 1275 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 155 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 199 | 0.020 |
Why?
|
| Survival Rate | 1 | 1998 | 2041 | 0.020 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 1993 | 25 | 0.020 |
Why?
|
| Physician's Role | 1 | 2015 | 181 | 0.020 |
Why?
|
| Kinetocardiography | 1 | 2013 | 1 | 0.020 |
Why?
|
| Neuromuscular Monitoring | 1 | 2013 | 3 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 3022 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2014 | 186 | 0.020 |
Why?
|
| Decision Making | 1 | 1998 | 686 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 1994 | 166 | 0.020 |
Why?
|
| Spinal Diseases | 1 | 1993 | 96 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 1031 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 14 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 1948 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1967 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2017 | 2531 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1513 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2015 | 520 | 0.020 |
Why?
|
| Pregnancy | 2 | 2017 | 3244 | 0.020 |
Why?
|
| Supine Position | 1 | 2010 | 34 | 0.020 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2011 | 82 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2005 | 346 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2787 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 360 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 658 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 795 | 0.020 |
Why?
|
| Neuromuscular Junction | 2 | 2002 | 85 | 0.020 |
Why?
|
| Acceleration | 1 | 2008 | 20 | 0.020 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1988 | 3 | 0.020 |
Why?
|
| Conjunctiva | 1 | 1988 | 14 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2011 | 418 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2011 | 381 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1988 | 370 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2008 | 236 | 0.020 |
Why?
|
| Suction | 1 | 1987 | 47 | 0.020 |
Why?
|
| Respiration | 1 | 2008 | 275 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 1987 | 66 | 0.020 |
Why?
|
| Tracheostomy | 1 | 1987 | 48 | 0.020 |
Why?
|
| Radiography | 2 | 1993 | 763 | 0.020 |
Why?
|
| Midazolam | 1 | 2006 | 48 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1986 | 40 | 0.010 |
Why?
|
| Platelet Count | 1 | 1986 | 94 | 0.010 |
Why?
|
| Hemodilution | 1 | 2006 | 14 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 194 | 0.010 |
Why?
|
| Nursing Care | 1 | 2005 | 3 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2005 | 50 | 0.010 |
Why?
|
| Neostigmine | 1 | 2005 | 6 | 0.010 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2005 | 45 | 0.010 |
Why?
|
| Caregivers | 1 | 2005 | 201 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 2022 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 2003 | 45 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2006 | 541 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 351 | 0.010 |
Why?
|
| Perfusion | 1 | 2004 | 271 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 2013 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2002 | 282 | 0.010 |
Why?
|
| Communication | 1 | 2005 | 456 | 0.010 |
Why?
|
| Arm | 1 | 1982 | 100 | 0.010 |
Why?
|
| Punctures | 1 | 2000 | 29 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2001 | 389 | 0.010 |
Why?
|
| Ethchlorvynol | 1 | 1980 | 2 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2006 | 10962 | 0.010 |
Why?
|
| Swine | 1 | 2001 | 593 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 175 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 4026 | 0.010 |
Why?
|
| Body Temperature | 1 | 1998 | 127 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1998 | 179 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1982 | 1568 | 0.010 |
Why?
|
| Child | 1 | 1988 | 7699 | 0.010 |
Why?
|
| Ulnar Nerve | 1 | 1995 | 7 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1995 | 102 | 0.010 |
Why?
|
| Animals | 2 | 2001 | 28902 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1196 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1994 | 47 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 412 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1994 | 32 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 226 | 0.010 |
Why?
|
| Mice | 1 | 1988 | 12697 | 0.010 |
Why?
|
| Intervertebral Disc | 1 | 1993 | 32 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1993 | 57 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 1993 | 50 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 120 | 0.010 |
Why?
|
| Algorithms | 1 | 2001 | 2009 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1950 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1998 | 802 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 1993 | 250 | 0.010 |
Why?
|
| Reoperation | 1 | 1993 | 726 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1980 | 212 | 0.000 |
Why?
|